DK0526540T3 - Anvendelse af 5-HT4-receptor-antagonister i behandlingen af atrieflimren, herunder forebyggelse af slagtilfælde - Google Patents

Anvendelse af 5-HT4-receptor-antagonister i behandlingen af atrieflimren, herunder forebyggelse af slagtilfælde

Info

Publication number
DK0526540T3
DK0526540T3 DK91908623T DK91908623T DK0526540T3 DK 0526540 T3 DK0526540 T3 DK 0526540T3 DK 91908623 T DK91908623 T DK 91908623T DK 91908623 T DK91908623 T DK 91908623T DK 0526540 T3 DK0526540 T3 DK 0526540T3
Authority
DK
Denmark
Prior art keywords
treatment
receptor antagonists
atrial fibrillation
including stroke
stroke prevention
Prior art date
Application number
DK91908623T
Other languages
Danish (da)
English (en)
Inventor
Alberto Julio Kaumann
Francis David King
Original Assignee
Beecham Group Plc
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc, Smith Kline French Lab filed Critical Beecham Group Plc
Application granted granted Critical
Publication of DK0526540T3 publication Critical patent/DK0526540T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Polarising Elements (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DK91908623T 1990-04-26 1991-04-24 Anvendelse af 5-HT4-receptor-antagonister i behandlingen af atrieflimren, herunder forebyggelse af slagtilfælde DK0526540T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909009389A GB9009389D0 (en) 1990-04-26 1990-04-26 Treatment
PCT/GB1991/000650 WO1991016045A2 (en) 1990-04-26 1991-04-24 Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke

Publications (1)

Publication Number Publication Date
DK0526540T3 true DK0526540T3 (da) 1999-11-22

Family

ID=10675031

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91908623T DK0526540T3 (da) 1990-04-26 1991-04-24 Anvendelse af 5-HT4-receptor-antagonister i behandlingen af atrieflimren, herunder forebyggelse af slagtilfælde

Country Status (14)

Country Link
EP (1) EP0526540B1 (pt)
JP (2) JPH05509293A (pt)
AT (1) ATE181668T1 (pt)
AU (1) AU653521B2 (pt)
CA (1) CA2081344C (pt)
DE (1) DE69131398T2 (pt)
DK (1) DK0526540T3 (pt)
ES (1) ES2134774T3 (pt)
GB (1) GB9009389D0 (pt)
GR (1) GR3031042T3 (pt)
IE (1) IE911383A1 (pt)
PT (1) PT97477B (pt)
WO (1) WO1991016045A2 (pt)
ZA (1) ZA913071B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128172A1 (en) 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
EP0664794A1 (en) * 1992-10-16 1995-08-02 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
US5684003A (en) * 1994-10-20 1997-11-04 Nisshin Flour Milling Co., Ltd. 5-HT4 receptor agonists
PL365048A1 (en) * 2000-08-07 2004-12-27 Laboratoire Glaxosmithkline S.A.S. Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
AU2005254800B2 (en) 2004-06-15 2010-12-09 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
EP2153830A1 (en) * 2008-08-07 2010-02-17 Sanofi-Aventis Use of dronedarone for the preparation of a medicament intended for the prevention of stroke or transient ischemic attack
PL3176164T3 (pl) 2014-07-30 2020-05-18 Aetas Pharma Co. Ltd. Izomer optyczny pochodnej 1-tlenku 1,4-benzotiazepiny oraz farmaceutyczna kompozycja wytworzona z jego użyciem

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687080T2 (de) * 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
US4731643A (en) * 1985-10-21 1988-03-15 International Business Machines Corporation Logic-circuit layout for large-scale integrated circuits

Also Published As

Publication number Publication date
CA2081344A1 (en) 1991-10-27
PT97477B (pt) 1998-08-31
ZA913071B (en) 1992-11-25
WO1991016045A2 (en) 1991-10-31
PT97477A (pt) 1992-01-31
ATE181668T1 (de) 1999-07-15
EP0526540A1 (en) 1993-02-10
JP2003267890A (ja) 2003-09-25
IE911383A1 (en) 1991-11-06
AU653521B2 (en) 1994-10-06
EP0526540B1 (en) 1999-06-30
WO1991016045A3 (en) 1991-12-26
DE69131398D1 (de) 1999-08-05
AU7768091A (en) 1991-11-11
CA2081344C (en) 2003-10-21
GB9009389D0 (en) 1990-06-20
GR3031042T3 (en) 1999-12-31
JPH05509293A (ja) 1993-12-22
DE69131398T2 (de) 2000-03-02
ES2134774T3 (es) 1999-10-16

Similar Documents

Publication Publication Date Title
NO924619L (no) (+)-alfa-(2,3-dimetoksyfenyl)-1-(2-(4-fluorfenyl)ethyl)-4-piperidinmetanol
DK0526540T3 (da) Anvendelse af 5-HT4-receptor-antagonister i behandlingen af atrieflimren, herunder forebyggelse af slagtilfælde
NL193399B (nl) Injecteerbare implantsamenstelling voor gebruik bij reconstructieve chirurgische behandelingen.
MX9202132A (es) Imidazobenzoquinonas y composicion que las contienen para prevenir o tratar la hipertension o el fallo cardiaco congestivo.
DE69133390D1 (de) Verwendung von angiotensin-ii-rezeptorantagonisten in der behandlung von hämorragischem schlaganfall
BR9708109A (pt) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinametanol no tratamento de distúrbios depressivos e distúrbios bipolares
DE69132782D1 (de) Verwendung von angiotensin-ii-antagonisten in der behandlung der linken ventrikulären hypertrophie
DK0468258T3 (da) Substituerede pyridooxaziner
DE69208681D1 (de) Verwendungen von 1,1,1,3,3,3-hexafluoropropan
DE69104458T2 (de) Fluorenthaltendes Copolymer und vernetzbare Zusammensetzung, welche dasselbe enthält.
NO922437D0 (no) Terapeutisk aktive fluorsubstituerte benzimidazoler, fremgangsmaate for deres fremstilling samt deres anvendelse
SE9403861D0 (sv) Novel medicinal use
IT1224610B (it) Aglio privo di odore e durevole eprocedimento per ottenere il medesimo
ES2129047T3 (es) Metodo para mejorar la memoria y la calidad de vida.
ES1014294Y (es) Tirador para puertas de muebles y similares.
FI901607A0 (fi) Laekemedel och dess anvaendning foer behandling av parasitos.
IT1238603B (it) Valvola cardiaca artificiale, con elevatissimo grado di sicurezza
ATA22989A (de) Behandlungsliege, insbesondere massageliege
DE69106720D1 (de) Mentholderivate mit spasmolytik aktivität.
BR6900443U (pt) Disposicao introduzida em valvula cardiaca
ES1020183Y (es) Panel perfeccionado de madera para la formacion de puertas, marcos y similares.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
ES1015049Y (es) Cantonera para puertas de madera y similares.
BR6802599U (pt) Disposicao introduzida em valvula cardiaca
BR1100532A (pt) (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorfenil)etil]-4-pipe ridinometanol e composição contendo o mesmo